Celldex Therapeutics
CLDX
#4573
Rank
A$2.66 B
Marketcap
$40.23
Share price
-0.68%
Change (1 day)
-5.80%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2024 : A$1.15 Billion

According to Celldex Therapeutics's latest financial reports the company has A$1.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.62 B38.74%
2022-12-31A$0.44 B-20.42%
2021-12-31A$0.56 B122.71%
2020-12-31A$0.25 B174.96%
2019-12-31A$91.95 M-31.1%
2018-12-31A$0.13 B-25.27%
2017-12-31A$0.17 B-32.17%
2016-12-31A$0.26 B-33.84%
2015-12-31A$0.39 B61.99%
2014-12-31A$0.24 B-27.68%
2013-12-31A$0.33 B320.42%
2012-12-31A$80.79 M55.39%
2011-12-31A$51.99 M-13.56%
2010-12-31A$60.14 M-34.47%
2009-12-31A$91.78 M46.32%
2008-12-31A$62.72 M1017.08%
2007-12-31A$5.61 M-89.18%
2006-12-31A$51.89 M62.15%
2005-12-31A$32 M-21.97%
2004-12-31A$41.01 M50.55%
2003-12-31A$27.24 M-38.77%
2002-12-31A$44.49 M-46.77%
2001-12-31A$83.6 M-6.84%
2000-12-31A$89.74 M333.02%
1999-12-31A$20.72 M42.59%
1998-12-31A$14.53 M47.97%
1997-12-31A$9.82 M-38.07%
1996-12-31A$15.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.89 B 63.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-87.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.10 B-90.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$13.82 B 1,091.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.26 B 1,216.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.59 B 468.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$6.27 M-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA